XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Equity
 9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Equity Equity
The following summarizes the changes in equity for the nine months ended September 30, 2021 (dollars in thousands):
Common
stock		Additional
paid-in
capital		Accumulated
earnings
less
dividends		Accumulated
other
comprehensive
loss		Total stockholder's equityNoncontrolling interestsTotal
equity
Balance at December 31, 2020$1,395 $10,664,416 $126,022 $(40,250)$10,751,583 $591 $10,752,174 
Net income attributable to common stockholders— — 142,223 — 142,223 — 142,223 
Cash flow hedge losses reclassified to earnings— — — 2,367 2,367 — 2,367 
Change in redemption value of redeemable noncontrolling interest— — (273)— (273)— (273)
Noncontrolling interest distribution and income allocation— — — — — (16)(16)
Dividends declared to common stockholders ($1.59 per share)
— — (221,779)— (221,779)— (221,779)
Issuance of common stock, net of withholdings1 (14,037)958 — (13,078)— (13,078)
Amortization of deferred compensation— 7,286 — — 7,286 — 7,286 
Balance at March 31, 2021$1,396 $10,657,665 $47,151 $(37,883)$10,668,329 $575 $10,668,904 
Net income attributable to common stockholders— — 447,953 — 447,953 — 447,953 
Loss on cash flow hedges, net— — — (822)(822)— (822)
Cash flow hedge losses reclassified to earnings— — — 2,366 2,366 — 2,366 
Change in redemption value of redeemable noncontrolling interest— — (255)— (255)— (255)
Noncontrolling interest distribution and income allocation— — — — — (7)(7)
Dividends declared to common stockholders ($1.59 per share)
— — (222,451)— (222,451)— (222,451)
Issuance of common stock, net of withholdings— 2,496 — — 2,496 — 2,496 
Amortization of deferred compensation— 10,403 — — 10,403 — 10,403 
Balance at June 30, 2021$1,396 $10,670,564 $272,398 $(36,339)$10,908,019 $568 $10,908,587 
Net income attributable to common stockholders— — 78,914 — 78,914 — 78,914 
Gain on cash flow hedges, net— — — 2,010 2,010 — 2,010 
Cash flow hedge losses reclassified to earnings— — — 7,405 7,405 — 7,405 
Change in redemption value of redeemable noncontrolling interest— — (261)— (261)— (261)
Noncontrolling interest distribution and income allocation— — — — — 2 2 
Dividends declared to common stockholders ($1.59 per share)
— — (222,475)— (222,475)— (222,475)
Issuance of common stock, net of withholdings— 4,633 (27)— 4,606 — 4,606 
Amortization of deferred compensation— 9,442 — — 9,442 — 9,442 
Balance at September 30, 2021$1,396 $10,684,639 $128,549 $(26,924)$10,787,660 $570 $10,788,230 
The following summarizes the changes in equity for the nine months ended September 30, 2020 (dollars in thousands):
Common
stock		Additional
paid-in
capital		Accumulated
earnings
less
dividends		Accumulated
other
comprehensive
loss		Total stockholder's equityNoncontrolling interestsTotal
equity
Balance at December 31, 2019$1,406 $10,736,733 $282,913 $(31,503)$10,989,549 $649 $10,990,198 
Net income attributable to common stockholders— — 167,971 — 167,971 — 167,971 
Loss on cash flow hedges, net— — — (17,603)(17,603)— (17,603)
Cash flow hedge losses reclassified to earnings— — — 1,949 1,949 — 1,949 
Change in redemption value of redeemable noncontrolling interest— — 471 — 471 — 471 
Noncontrolling interests income allocation— — — — — (35)(35)
Dividends declared to common stockholders ($1.59 per share)
— — (224,083)— (224,083)— (224,083)
Issuance of common stock, net of withholdings1 (12,492)(1,616)— (14,107)— (14,107)
Amortization of deferred compensation— 7,781 — — 7,781 — 7,781 
Balance at March 31, 2020$1,407 $10,732,022 $225,656 $(47,157)$10,911,928 $614 $10,912,542 
Net income attributable to common stockholders— — 170,828 — 170,828 — 170,828 
Loss on cash flow hedges, net— — — (1,461)(1,461)— (1,461)
Cash flow hedge losses reclassified to earnings— — — 2,301 2,301 — 2,301 
Change in redemption value of redeemable noncontrolling interest— — (146)— (146)— (146)
Noncontrolling interests income allocation— — — — — 1 1 
Dividends declared to common stockholders ($1.59 per share)
— — (224,172)— (224,172)— (224,172)
Issuance of common stock, net of withholdings— 1,050 138 — 1,188 — 1,188 
Amortization of deferred compensation— 9,724 — — 9,724 — 9,724 
Balance at June 30, 2020$1,407 $10,742,796 $172,304 $(46,317)$10,870,190 $615 $10,870,805 
Net income attributable to common stockholders— — 147,703 — 147,703 — 147,703 
Gain on cash flow hedges, net— — — 1,333 1,333 — 1,333 
Cash flow hedge losses reclassified to earnings— — — 2,367 2,367 — 2,367 
Change in redemption value of redeemable noncontrolling interest— — 62 — 62 — 62 
Noncontrolling interest distribution and income allocation— — — — — (17)(17)
Dividends declared to common stockholders ($1.59 per share)
— — (222,694)— (222,694)— (222,694)
Issuance of common stock, net of withholdings— 105 — — 105 — 105 
Repurchase of common stock, including repurchase costs(9)(69,779)(67,670)— (137,458)— (137,458)
Amortization of deferred compensation— 8,036 — — 8,036 — 8,036 
Balance at September 30, 2020$1,398 $10,681,158 $29,705 $(42,617)$10,669,644 $598 $10,670,242 

As of September 30, 2021 and December 31, 2020, the Company's charter had authorized for issuance a total of 280,000,000 shares of common stock and 50,000,000 shares of preferred stock.
During the nine months ended September 30, 2021, the Company:

i.issued 2,126 shares of common stock in connection with stock options exercised;
ii.issued 2,223 shares of common stock through the Company's dividend reinvestment plan;
iii.issued 153,379 shares of common stock in connection with restricted stock grants and the conversion of performance awards to shares of common stock;
iv.sold 21,000 shares of common stock under CEP V, as discussed below;
v.withheld 75,542 shares of common stock to satisfy employees' tax withholding and other liabilities;
vi.issued 12,145 shares of common stock through the Employee Stock Purchase Plan; and
vii.canceled 3,077 shares of restricted common stock upon forfeiture.

Any deferred compensation related to the Company's stock option, restricted stock and performance award grants as of September 30, 2021 is not reflected on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2021, and will not be reflected until recognized as compensation cost.

In July 2020, the Company’s Board of Directors voted to terminate the Company’s prior $500,000,000 Stock Repurchase Program (the "Amended 2005 Stock Repurchase Program") and approved a new stock repurchase program under which the Company may acquire shares of its common stock in open market or negotiated transactions up to an aggregate purchase price of $500,000,000 (the "2020 Stock Repurchase Program"). Purchases of common stock under the 2020 Stock Repurchase Program may be exercised from time to time in the Company’s discretion and in such amounts as market conditions warrant. The timing and actual number of shares repurchased will depend on a variety of factors, including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The 2020 Stock Repurchase Program does not have an expiration date and may be suspended or terminated at any time without prior notice. During the nine months ended September 30, 2021, the Company had no repurchases of shares under this program. As of September 30, 2021, the Company had $316,148,000 remaining authorized for purchase under this program.

In May 2019, the Company commenced a fifth continuous equity program ("CEP V") under which the Company may sell (and/or enter into forward sale agreements for the sale of) up to $1,000,000,000 of its common stock from time to time. Actual sales will depend on a variety of factors to be determined by the Company, including market conditions, the trading price of the Company's common stock and determinations by the Company of the appropriate sources of funding for the Company. In conjunction with CEP V, the Company engaged sales agents who will receive compensation of up to 1.5% of the gross sales price for shares sold. The Company expects that, if entered into, it will physically settle each forward sale agreement on one or more dates specified by the Company on or prior to the maturity date of that particular forward sale agreement, in which case the Company will expect to receive aggregate net cash proceeds at settlement equal to the number of shares underlying the particular forward agreement multiplied by the relevant forward sale price. However, the Company may also elect to cash settle or net share settle a forward sale agreement. In connection with each forward sale agreement, the Company will pay the relevant forward seller, in the form of a reduced initial forward sale price, a commission of up to 1.5% of the sales prices of all borrowed shares of common stock sold. During the three and nine months ended September 30, 2021, the Company sold 21,000 shares of common stock at an average sales price of $227.60 per share, for net proceeds of $4,708,000 under the program. As of September 30, 2021, the Company had $748,099,000 remaining authorized for issuance under CEP V.